Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

Nilesh W. Gaikwad, Li Yang, Dennis D. Weisenburger, Julie Vose, Cheryl Beseler, Eleanor G. Rogan, Ercole L. Cavalieri

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A variety of evidence suggests that estrogens may induce non-Hodgkin lymphoma (NHL). The reaction of catechol estrogen quinones with DNA to form depurinating estrogen-DNA adducts is hypothesized to initiate this process. These adducts are released from DNA, shed from cells into the bloodstream and excreted in urine. The aim of this study was to determine whether or not the depurinating estrogen-DNA adducts might be involved in the aetiology of human NHL. Estrogen metabolites, conjugates and depurinating DNA adducts were identified and quantified in spot urine samples from 15 men with NHL and 30 healthy control men by using ultraperformance liquid chromatography/tandem mass spectrometry. The levels of estrogen-DNA adducts were significantly higher in the men with NHL than in the healthy control men. Thus, formation of estrogen-DNA adducts may play a critical role in the aetiology of NHL, and these adducts could be potential biomarkers of NHL risk.

Original languageEnglish (US)
Pages (from-to)502-512
Number of pages11
JournalBiomarkers
Volume14
Issue number7
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

DNA Adducts
Biomarkers
Non-Hodgkin's Lymphoma
Estrogens
Catechol Estrogens
Urine
Quinones
DNA
Liquid chromatography
Metabolites
Tandem Mass Spectrometry
Liquid Chromatography
Mass spectrometry

Keywords

  • Depurinating estrogen-DNA adducts
  • Non-Hodgkin lymphoma
  • Solid-phase extraction
  • Urinary biomarkers

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

Gaikwad, N. W., Yang, L., Weisenburger, D. D., Vose, J., Beseler, C., Rogan, E. G., & Cavalieri, E. L. (2009). Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma. Biomarkers, 14(7), 502-512. https://doi.org/10.3109/13547500903121715

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma. / Gaikwad, Nilesh W.; Yang, Li; Weisenburger, Dennis D.; Vose, Julie; Beseler, Cheryl; Rogan, Eleanor G.; Cavalieri, Ercole L.

In: Biomarkers, Vol. 14, No. 7, 2009, p. 502-512.

Research output: Contribution to journalArticle

Gaikwad, NW, Yang, L, Weisenburger, DD, Vose, J, Beseler, C, Rogan, EG & Cavalieri, EL 2009, 'Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma', Biomarkers, vol. 14, no. 7, pp. 502-512. https://doi.org/10.3109/13547500903121715
Gaikwad, Nilesh W. ; Yang, Li ; Weisenburger, Dennis D. ; Vose, Julie ; Beseler, Cheryl ; Rogan, Eleanor G. ; Cavalieri, Ercole L. / Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma. In: Biomarkers. 2009 ; Vol. 14, No. 7. pp. 502-512.
@article{3880ace90aeb4d8492a2e735152d437d,
title = "Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma",
abstract = "A variety of evidence suggests that estrogens may induce non-Hodgkin lymphoma (NHL). The reaction of catechol estrogen quinones with DNA to form depurinating estrogen-DNA adducts is hypothesized to initiate this process. These adducts are released from DNA, shed from cells into the bloodstream and excreted in urine. The aim of this study was to determine whether or not the depurinating estrogen-DNA adducts might be involved in the aetiology of human NHL. Estrogen metabolites, conjugates and depurinating DNA adducts were identified and quantified in spot urine samples from 15 men with NHL and 30 healthy control men by using ultraperformance liquid chromatography/tandem mass spectrometry. The levels of estrogen-DNA adducts were significantly higher in the men with NHL than in the healthy control men. Thus, formation of estrogen-DNA adducts may play a critical role in the aetiology of NHL, and these adducts could be potential biomarkers of NHL risk.",
keywords = "Depurinating estrogen-DNA adducts, Non-Hodgkin lymphoma, Solid-phase extraction, Urinary biomarkers",
author = "Gaikwad, {Nilesh W.} and Li Yang and Weisenburger, {Dennis D.} and Julie Vose and Cheryl Beseler and Rogan, {Eleanor G.} and Cavalieri, {Ercole L.}",
year = "2009",
doi = "10.3109/13547500903121715",
language = "English (US)",
volume = "14",
pages = "502--512",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

AU - Gaikwad, Nilesh W.

AU - Yang, Li

AU - Weisenburger, Dennis D.

AU - Vose, Julie

AU - Beseler, Cheryl

AU - Rogan, Eleanor G.

AU - Cavalieri, Ercole L.

PY - 2009

Y1 - 2009

N2 - A variety of evidence suggests that estrogens may induce non-Hodgkin lymphoma (NHL). The reaction of catechol estrogen quinones with DNA to form depurinating estrogen-DNA adducts is hypothesized to initiate this process. These adducts are released from DNA, shed from cells into the bloodstream and excreted in urine. The aim of this study was to determine whether or not the depurinating estrogen-DNA adducts might be involved in the aetiology of human NHL. Estrogen metabolites, conjugates and depurinating DNA adducts were identified and quantified in spot urine samples from 15 men with NHL and 30 healthy control men by using ultraperformance liquid chromatography/tandem mass spectrometry. The levels of estrogen-DNA adducts were significantly higher in the men with NHL than in the healthy control men. Thus, formation of estrogen-DNA adducts may play a critical role in the aetiology of NHL, and these adducts could be potential biomarkers of NHL risk.

AB - A variety of evidence suggests that estrogens may induce non-Hodgkin lymphoma (NHL). The reaction of catechol estrogen quinones with DNA to form depurinating estrogen-DNA adducts is hypothesized to initiate this process. These adducts are released from DNA, shed from cells into the bloodstream and excreted in urine. The aim of this study was to determine whether or not the depurinating estrogen-DNA adducts might be involved in the aetiology of human NHL. Estrogen metabolites, conjugates and depurinating DNA adducts were identified and quantified in spot urine samples from 15 men with NHL and 30 healthy control men by using ultraperformance liquid chromatography/tandem mass spectrometry. The levels of estrogen-DNA adducts were significantly higher in the men with NHL than in the healthy control men. Thus, formation of estrogen-DNA adducts may play a critical role in the aetiology of NHL, and these adducts could be potential biomarkers of NHL risk.

KW - Depurinating estrogen-DNA adducts

KW - Non-Hodgkin lymphoma

KW - Solid-phase extraction

KW - Urinary biomarkers

UR - http://www.scopus.com/inward/record.url?scp=70449354725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449354725&partnerID=8YFLogxK

U2 - 10.3109/13547500903121715

DO - 10.3109/13547500903121715

M3 - Article

VL - 14

SP - 502

EP - 512

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 7

ER -